Research Solutions Inc. (NASDAQ:RSSS) Short Interest Update

Key Points

• Research Solutions Inc. experienced a 30% decline in short interest in August, with totals dropping from 20,000 to 14,000 shares as of August 31st.
• The company's stock is currently priced at $3.37 with a market capitalization of $109.39 million and a P/E ratio of -24.07.
• Institutional investors own 33.60% of Research Solutions, with recent investments from firms like Northern Trust Corp and Millennium Management LLC.

Research Solutions Inc. (NASDAQ:RSSS - Get Free Report) was the target of a large decrease in short interest in the month of August. As of August 31st, there was short interest totaling 14,000 shares, a decrease of 30.0% from the August 15th total of 20,000 shares. Based on an average daily volume of 60,700 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.0% of the shares of the stock are sold short. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 60,700 shares, the days-to-cover ratio is currently 0.2 days.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Evernest Financial Advisors LLC purchased a new position in Research Solutions in the second quarter valued at approximately $35,000. Cubist Systematic Strategies LLC purchased a new stake in shares of Research Solutions during the fourth quarter valued at approximately $56,000. Millennium Management LLC purchased a new stake in shares of Research Solutions during the fourth quarter valued at approximately $65,000. NewEdge Advisors LLC purchased a new stake in shares of Research Solutions during the first quarter valued at approximately $71,000. Finally, Topline Capital Management LLC purchased a new stake in shares of Research Solutions during the second quarter valued at approximately $125,000. Hedge funds and other institutional investors own 33.60% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Roth Capital increased their price objective on shares of Research Solutions from $4.35 to $5.00 and gave the company a "buy" rating in a research note on Friday. One analyst has rated the stock with a Buy rating, According to MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $5.00.

Research Solutions Trading Down 6.9%

Shares of Research Solutions stock traded down $0.27 during mid-day trading on Friday, hitting $3.66. 852,622 shares of the stock were exchanged, compared to its average volume of 111,929. Research Solutions has a twelve month low of $2.32 and a twelve month high of $4.24. The stock has a market capitalization of $118.80 million, a price-to-earnings ratio of 122.04, a price-to-earnings-growth ratio of 4.37 and a beta of 0.66. The company has a 50-day simple moving average of $2.97 and a 200 day simple moving average of $2.84.

Research Solutions (NASDAQ:RSSS - Get Free Report) last announced its quarterly earnings data on Thursday, September 18th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.04. The business had revenue of $12.44 million for the quarter, compared to analyst estimates of $12.51 million. Research Solutions had a net margin of 2.58% and a return on equity of 10.81%. During the same period in the prior year, the firm posted ($0.08) EPS. Equities research analysts forecast that Research Solutions will post 0.05 earnings per share for the current fiscal year.

About Research Solutions

Research Solutions, Inc, through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover platform that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including free basic search solutions and advanced search tools, which include the Resolute.ai and scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer's internal datasets.